According to the DEA, they hold the ultimate decision-making power to schedule, reschedule, or deschedule a drug according to the Controlled Substances Act. They explain that the decision was made after considering relevant statutory and regulatory criteria and the scientific and medical evaluation conducted by the Department of Health and Human Services (HHS). Currently, the DEA is actively conducting its comprehensive review.”
Trulieve becomes the first U.S. cannabis company to trade on the NYSE on June 10.…
From robot canopy scanners to algorithmic breeders to AI-powered dispensary counters, artificial intelligence is remaking…
The latest version of this story comes from Virginia Commonwealth University, where researcher Emanuele Alves…
But there's more to this image than nostalgia and comedy. What you're looking at in…
The league pulled marijuana off its banned list in the new players’ agreement. In the…
In New South Wales, Australia, patients can legally use medical cannabis with a prescription. So…